We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
In a postmarket study, Vasc-Alert’s surveillance technology successfully identified high-risk dialysis patients, a group seven times more likely to experience blood vessel narrowing, researchers reported in the Journal of Vascular Access.
BioIntelliSense and care.ai have teamed up to combine their existing technologies to provide continuous monitoring from medical-grade wearables to improve clinical workflows in healthcare facilities.
Ibex Medical Analytics’s Galen Breast artificial intelligence (AI) diagnostic tool showed high accuracy in detecting breast cancer from biopsies, researchers reported in the journal Breast Cancer. Read More
Back pain sufferers using DarioHealth’s UpRight posture biofeedback platform at least six hours a day for four weeks saw significantly reduced pain and improved posture, researchers from the company reported in the journal Frontiers in Physiology.Read More
Oxford BioDynamics’ EpiSwitch blood biomarker assay for amyotrophic lateral sclerosis (ALS) showed which patients were likely to have a fast or slow progressing disease, the company said, citing interim results from a multicenter trial.
Guardant Health’s investigational blood test to detect colorectal cancer in average-risk adults showed promising results in a 20,000-participant study evaluating what would be the first blood test available in the U.S. to scan for colorectal cancer.